AI-ENABLED PRECISION THERAPEUTICS
Advancing novel small molecule therapeutics for complex chronic diseases
Transforming Molecules to Medicines
AI-ENABLED DISCOVERY
COMPUTATIONAL CHEMISTRY
PRECISION DRUG DESIGN
TRANSLATIONAL PHARMACOLOGY
PRECISION DEUTERIUM STRATEGY
OUR PLATFORM
Transforming Molecules to Medicines
INVENT Pharmaceuticals is developing novel therapeutics for cardiovascular, renal, pulmonary, vascular, fibrotic and neurodegenerative diseases, psychiatric disorders and neuroendocrine tumors.
OUR SCIENTIFIC PLATFORM
AI-ENABLED DISCOVERY
Accelerating and enhancing drug discovery and development of medicines for serious diseases
TRANSLATIONAL Drug Discovery and Development
Proprietary drug design and discovery of novel and innovative medicines
PRECISION DRUG DESIGN
De-risking novel drug candidates for high efficacy, selectivity and safety of therapeutics by precision drug design
Integrated Capabilities. Transformative therapies.
OUR PIPELINE
A differentiated pipeline created by precision drug discovery
Our pipeline of differentiated small molecule therapeutics is targeting diseases of medical need. Each program is advancing through a disciplined science and data-driven development engine.
Targeting complex disease biology with precision
Building the next generation of precision therapeutics.
info@inventpharma.com
THERAPEUTIC AREAS
Cardiovascular & Renal
Pulmonary Disease
Neurology & CNS
Oncology
Interconnected cardiometabolic disease biology.
Advancing precision therapeutics across complex chronic disease. Our deep
Metabolic Disease
Focused on neurodegenerative and neuropsychiatric disease mechanisms.
Addressing progressive fibrotic disease biology across organ systems.
Developing treatments for chronic metabolic dysfunction and related complications
Advancing therapies for severe pulmonary and cardiopulmonary disorders.
THERAPEUTIC FOCUS AREAS
CARDIOVASCULAR & RENAL
Targeting interconnected cardiometabolic and renal disease pathways.
PULMONARY DISEASE
Advancing therapies for severe pulmonary and cardiopulmonary disorders.
NEUROLOGY & CNS
Developing treatments for chronic metabolic dysfunction and related complications.
METABOLIC DISEASE
ONCOLOGY
Addressing progressive fibrotic disease biology across organ systems.
Focused on neurodegenerative and neuropsychiatric disease mechanisms.
© 2026 INVENT Pharmaceuticals. All rights reserved.